南京金斯瑞生物科技有限公司

About 南京金斯瑞生物科技有限公司

Founded in 2002, Genscript has grown with synthetic biology to become the world's largest gene synthesis supplier. Headquartered in New Jersey, Genscript has branches in Europe, Japan, and China, with a sales network covering over 100 countries and regions worldwide. We are consistently dedicated to providing the best research services to the global scientific community. As of September 2014, Genscript has established good service relationships with over 130,000 clients from pharmaceutical companies, biotechnology companies, and research institutions worldwide. Our work has been cited over 12,000 times in more than 1,400 international journals, including high-impact journals such as Nature, Science, and Cell, making us the most cited bio-CRO company. We have established biological research services with optimal throughput and quality, including gene synthesis, molecular biology services, peptide synthesis, custom antibody production, protein expression, antibody engineering, protein engineering, as well as in vitro and in vivo pharmacodynamic studies and industrial enzyme R&D, all aimed at simplifying scientific research. Genscript Features: High-quality office environment - Genscript has a registered capital of up to 100 million US dollars in the Nanjing Jiangning High-tech Development Zone, equipped with a 74,322 square meter R&D and production center. High-quality team - Genscript has over 2,000 employees globally, including over 200 overseas returnees and over 600 high-quality Master's and PhD holders. Joining Genscript offers the opportunity to work alongside them and grow rapidly in your professional career. Global company - Genscript is headquartered in New Jersey, USA, with branches and subsidiaries in China, Europe, and Japan. Joining Genscript provides opportunities to work in different countries, experience diverse cultures, and develop an international perspective. Top international clients - Genscript's clients span over 100 countries and regions, covering more than 5,700 pharmaceutical, biotechnology companies, and research institutions worldwide. Joining Genscript allows you to engage with cutting-edge international projects, interact directly with top-tier clients, and collaborate with global elites. Pioneer in synthetic biology - The world's first commercially oriented artificial gene synthesis company and the largest gene synthesis supplier. Genscript was invited to participate in the Global Yeast Genome Project in 2012, completing the synthesis of the sixth artificial chromosome of 170kb. Diversified development - Breaking the monopoly of global giants, participating in the formulation of national enzyme preparation industry standards; our CAR-T product for treating multiple myeloma shows leading efficacy globally and was highly acclaimed at the ASCO conference in the US in June 2017.